|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4,605.00 KRW | +1.10% |
|
+5.26% | -15.81% |
| 05-12 | BioNote's Net Income Jumps 925% in Q1; Shares Rise 3% | MT |
| 05-12 | Bionote Inc Q1 provisional operating profit 6.3 billion won up 35.2% Y/Y | RE |
| Market Cap | 466B 301M 264M 243M 226M 427M 28.62B 436M 2.92B 1.13B 14.01B 1.13B 1.1B 48.98B | P/E 2024 |
8.69x | P/E 2025 | -6.32x |
|---|---|---|---|---|---|
| Enterprise Value | 130B 83.74M 73.61M 67.77M 63.09M 119M 7.97B 122M 815M 316M 3.9B 314M 308M 13.65B | EV / Sales 2024 |
0.77x | EV / Sales 2025 | 1.84x |
| Free-Float |
12.55% | Yield 2024 |
4.25% | Yield 2025 | - |
| 1 day | +1.10% | ||
| 1 week | +5.26% | ||
| Current month | +1.10% | ||
| 1 month | -5.83% | ||
| 3 months | -8.99% | ||
| 6 months | -15.81% | ||
| Current year | -15.81% |
| 1 week | 4,240 |  | 4,630 |
| 1 month | 4,240 | | 4,990 |
| Current year | 4,240 | | 6,260 |
| 1 year | 4,240 | | 6,320 |
| 3 years | 3,800 | | 6,460 |
| 5 years | 3,800 | | 11,700 |
| 10 years | 3,800 | | 11,700 |
| Manager | Title | Age | Since |
|---|---|---|---|
Byung-Ki Cho
CEO | Chief Executive Officer | 58 | 2020-07-31 |
Guk-Myung Lee
DFI | Director of Finance/CFO | 54 | 2021-03-31 |
Hye-Im Cho
SAM | Sales & Marketing | 39 | 2025-03-25 |
| Director | Title | Age | Since |
|---|---|---|---|
Young-Sik Cho
CHM | Chairman | 65 | 2023-02-28 |
Byung-Ki Cho
BRD | Director/Board Member | 58 | 2020-07-31 |
Jung-Ho Kim
BRD | Director/Board Member | 50 | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 25-02-04 | Don | Chairman | 10,000,000 | 9.8058% | ||
| 25-02-04 | Free | 10,000,000 | 9.8058% | |||
| 24-04-13 | Others | 6,729,843 | 6.5991% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.10% | +5.26% | -8.63% | +1.21% | 298M | |
| -3.02% | +12.59% | -10.95% | -29.81% | 3.28B | |
| +1.28% | +5.45% | +6.43% | -84.11% | 1.9B | |
| +3.04% | +0.20% | -42.94% | - | 51.01M | |
| Average | +0.60% | +6.90% | -14.02% | -37.57% | 1.38B | |
| Weighted average by Cap. | -1.27% | +11.20% | -5.15% | -46.94% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 103B 66.29M 58.28M 53.65M 49.95M 94.25M 6.31B 96.2M 645M 250M 3.09B 249M 243M 10.8B | 118B 76.32M 67.09M 61.76M 57.51M 109M 7.27B 111M 742M 288M 3.56B 287M 280M 12.44B |
| Net income | 55.26B 35.64M 31.33M 28.85M 26.86M 50.67M 3.39B 51.72M 347M 134M 1.66B 134M 131M 5.81B | -87.5B -56.44M -49.61M -45.67M -42.52M -80.24M -5.37B -81.9M -549M -213M -2.63B -212M -207M -9.2B |
| Net Debt | -401B -259M -228M -210M -195M -368M -24.66B -376M -2.52B -977M -12.07B -972M -951M -42.2B | -336B -217M -191M -175M -163M -308M -20.65B -315M -2.11B -818M -10.11B -814M -796M -35.33B |
Employees
298
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-01 | ₩4,605.00 | +1.10% | 64,956 |
| 26-06-30 | ₩4,555.00 | +1.00% | 40,624 |
| 26-06-29 | ₩4,510.00 | +3.32% | 109,363 |
| 26-06-26 | ₩4,365.00 | -1.69% | 82,218 |
| 26-06-25 | ₩4,440.00 | -0.22% | 86,058 |
- Stock Market
- Stocks
- A377740 Stock
Select your edition
All financial news and data tailored to specific country editions
